Edgar Faber

Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

Johan Richter, Joëlle Guilhot, Franz Gruber et al. · The Lancet Oncology · 2018 · 587 citations · Full text

Hematological Malignancy, Medicine, Chronic Myeloid Leukaemia +10

SALIVA AS A DIAGNOSTIC MEDIUM

Richard Pink, J Šimek, Jana Vondráková et al. · Biomedical Papers · 2009 · 146 citations · Full text

The effect of prior exposure to imatinib on transplant-related mortality.

Michael W. Deininger, Michael Schleuning, H. Greinix et al. · PubMed · 2006 · 114 citations

Discovery of novel drug sensitivities in T-PLL by high-throughput ex vivo drug testing and mutation profiling

Emma Andersson, S. Pützer, Bhagwan Yadav et al. · Leukemia · 2017 · 95 citations

Novel Drug Sensitivities, Pharmaceutical Research, Drug Target +12

The EUTOS long-term survival (ELTS) score is superior to the Sokal score for predicting survival in chronic myeloid leukemia

Markus Pfirrmann, Richard E. Clark, Witold Prejzner et al. · Leukemia · 2020 · 93 citations · Full text